First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.
- DOI
- 10.1002/pul2.70434
- Published
- 2026 Oct
- Container
- Pulmonary circulation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pul2.70434,
title = {First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.},
author = {Jabi MA and Sabbour H and Mohamed L and Alsultan S and Almassabi M and Osama M and Abudouleh A and Sondoqah M and Zaki MK and Hesham A and Saleh KM and Haque MUI and Preston I},
year = {2026},
journal = {Pulmonary circulation},
doi = {10.1002/pul2.70434},
url = {https://doi.org/10.1002/pul2.70434}
}RIS
TY - JOUR TI - First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study. AU - Jabi MA AU - Sabbour H AU - Mohamed L AU - Alsultan S AU - Almassabi M AU - Osama M AU - Abudouleh A AU - Sondoqah M AU - Zaki MK AU - Hesham A AU - Saleh KM AU - Haque MUI AU - Preston I PY - 2026 JO - Pulmonary circulation DO - 10.1002/pul2.70434 UR - https://doi.org/10.1002/pul2.70434 ER -
APA
MA, J., H, S., L, M., S, A., M, A., M, O., A, A., M, S., MK, Z., A, H., KM, S., MUI, H., & I, P. (2026). First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.. Pulmonary circulation. https://doi.org/10.1002/pul2.70434
Source records
- pubmed · retrieved 2026-11-10T10:48:51.586Z
- europe-pmc · retrieved 2026-11-10T10:48:51.577Z